Clinical Trial to Test Medication (CAN-002) in Participants Who Want to Stop Their Cannabis Use
Lay Description
A clinical trial to evaluate whether the study medication lessens withdrawal symptoms associated with stopping marijuana use in frequent marijuana users. This study is for generally healthy adults ages 18-55 who are interested in stopping their marijuana use. Participants must have capabilities for virtual/video telemedicine visits, and cannot be pregnant.
Category
- Substance Abuse
- Healthy Subjects Needed
- Behaviors and Mental Disorders
- Diabetes
- Diagnostic
- Emergency Medicine
- Family Health
- Lungs, Breathing and Bronchial
- Mens Health
- Minority Studies
- Rehabilitation
- Womens Health
- Wounds and Injuries
- IRB Number
- 20220435HU
- NCT Number
- NCT05494437
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- 18-55
- Eligible Genders
- all
- Accepts Healthy Volunteers
- No
Inclusion Criteria
18-55 age, healthy individuals, marijuana users who are interested in stopping their marijuana use, and have access to virtual/video telemedicine visits
Exclusion Criteria
Pregnant participants
Study Design
Arm Groups
Study Contact
Regulatory Point of Contact
Jennifer Potter
(210) 562-5698
potterjs@uthscsa.edu
Regulatory Point of Contact
Meenakshi Rani
(210) 567-5736
rani@uthscsa.edu
Regulatory Point of Contact
Jeannette Santos
(210) 567-2752
santosi@uthscsa.edu
Local Recruitment Point of Contact
Meenakshi Rani
(210) 567-5736
rani@uthscsa.edu
Local Recruitment Point of Contact
Jeannette Santos
(210) 567-2752
santosi@uthscsa.edu
Principal Investigator
Jennifer Potter